An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

I don’t hold on to them. I dwell for not more than 48 hours, then look at the brighter side. Meeting Amitabh Bachchan on the sets of Kaun Banega Crorepati Season 16. I pinched myself to make sure I ...

Caribou Biosciences recently announced positive phase 1 clinical data for its allogeneic CAR-T cell therapies, vispacabtagene regedleucel (vispa-cel) for relapsed or refractory B cell non-Hodgkin ...

Caribou Biosciences (CRBU) just shared early clinical findings from its CaMMouflage phase 1 study of CB-011, an off-the-shelf CAR-T therapy for relapsed or refractory multiple myeloma. The data brings ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Caribou Coffee, the premium coffeehouse known for handcrafted beverages and real ingredients, announces its holiday lineup, launching in stores nationwide beginning Saturday, Nov. 1. This season, ...

“The big one is on the left,” my Inuit guide, Amos Irkok, said with a twinge of excitement in his soft voice. I crawled up the back side of a bald, pebble-covered hilltop toward a coffee-table-sized ...

Elisabetta Canteri does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

ROCHESTER – Amid the construction of Rochester’s Link Rapid Transit on Second Street, a popular coffee shop in the Saint Marys Hospital neighborhood has gone as dark as a shot of espresso. Caribou ...

In my opinion there's no game director with a resume as impressive as Hideki Kamiya. Devil May Cry, Viewtiful Joe, and Bayonetta spawned legendary series' while Okami and The Wonderful 101 are both ...

Shares of Caribou Biosciences (NASDAQ:CRBU) will be in focus on Friday after the gene-editing biotech announced plans to prioritize its lead oncology clinical programs, CB-010 and CB-011, as part of a ...

Caribou Biosciences is winnowing down for the second time in the last year, dropping a leukemia CAR-T asset and laying off 32% of staff to home in on two lead allogeneic cell therapy candidates. The ...